Deucravacitinib
CAS 1609392-27-9
Em Estoque
Deucravacitinib
Cat. No. STUB-API-DEUCRAVACITINIBCAS 1609392-27-9Em Estoque
Dados Técnicos
Cat. No.STUB-API-DEUCRAVACITINIB
CAS1609392-27-9
Fórmula Mol.C20H22N8O3
Peso Mol.425.4673 g/mol
IUPAC6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide
SMILES[2H]C([2H])([2H])NC(=O)C1=NN=C(C=C1NC2=CC=CC(=C2OC)C3=NN(C=N3)C)NC(=O)C4CC4
InChIInChI=1S/C20H22N8O3/c1-21-20(30)16-14(9-15(25-26-16)24-19(29)11-7-8-11)23-13-6-4-5-12(17(13)31-3)18-22-10-28(2)27-18/h4-6,9-11H,7-8H2,1-3H3,(H,21,30)(H2,23,24,25,29)/i1D3
Chave InChIBZZKEPGENYLQSC-FIBGUPNXSA-N
Pureza—
Descrição
Visão geral
Deucravacitinib is a targeted treatment for patients with moderate-to-severe plaque psoriasis who qualify for systemic therapy or phototherapy
A Anant Labs fabrica e fornece impurezas de Deucravacitinib de alta qualidade para o mercado global. Nossas impurezas EP de Deucravacitinib são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.
Sinônimos
Deucravacitinib1609392-27-9BMS-986165SotyktuN0A21N6RAURefChem:58358Tyk2-IN-4BMS9861656-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamideDeucravacitinib [USAN]
